Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Stereotaxis Inc (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010836
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stereotaxis Inc (Stereotaxis) is a healthcare technology company that designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch Solution is an advanced remote robotic navigation system for use in interventional lab for the treatment of arrhythmias and coronary artery disease. The Epoch Solution consists of Niobe ES robotic magnetic navigation system, Odyssey information management solution and Vdrive robotic navigation system. It also offers maintenance and support services for its integrated products. The company markets its products and services through direct sales force and through strategic alliances with other companies in the US, Europe and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Stereotaxis Inc (STXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Stereotaxis Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Stereotaxis Amends Co-Development Agreement With Biosense Webster 11
Equity Offering 12
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 12
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 13
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 14
Stereotaxis Completes Private Placement Of Shares For US$10 Million 15
Stereotaxis Inc – Key Competitors 16
Stereotaxis Inc – Key Employees 17
Stereotaxis Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 19
Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 21
May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 22
Nov 07, 2016: Stereotaxis Reports 2016 Third Quarter Financial Results 23
Aug 09, 2016: Stereotaxis Reports 2016 Second Quarter Financial Results 25
May 09, 2016: Stereotaxis Reports 2016 First Quarter Financial Results 27
Corporate Communications 28
Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 28
Sep 27, 2016: Stereotaxis Announces Recruitment of Highly Experienced Board Members 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Stereotaxis Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Stereotaxis Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Stereotaxis Inc, Medical Devices Deals, 2011 to YTD 2017 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Stereotaxis Amends Co-Development Agreement With Biosense Webster 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 12
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 13
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 14
Stereotaxis Completes Private Placement Of Shares For US$10 Million 15
Stereotaxis Inc, Key Competitors 16
Stereotaxis Inc, Key Employees 17
Stereotaxis Inc, Other Locations 18
Stereotaxis Inc, Subsidiaries 18

★海外企業調査レポート[Stereotaxis Inc (STXS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eloxx Pharmaceuticals Inc (ELOX):企業の財務・戦略的SWOT分析
    Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, infl …
  • Almac Discovery Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Almac Discovery Ltd (Almac Discovery), a subsidiary of Almac Group Ltd is a healthcare service provider that discovers and develops drugs for the treatment of cancer. The company develops drugs, small molecule and therapeutic peptide, biomarkers and diagnostic tools. It provides early drug d …
  • Theravasc Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Theravasc Inc (Theravasc) is a pharmaceutical company that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product includes TV1001SR, a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases a …
  • Exmar NV (EXM):企業の財務・戦略的SWOT分析
    Summary Exmar NV (Exmar) a subsidiary of Compagnie Maritime Belge SA, operates as a shipping and energy supply chain solutions provider. The company's service portfolio includes liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and supporting services. Its LNG segment offers floating …
  • Trianni Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Trianni Inc (Trianni) is a developer of fully human monoclonal antibodies that provides its propriety discovery platform. The company provides Trianni Mouse platform that holds engineered versions of three antibody-encoding genetic loci, namely, Heavy, Kappa, Lambda, and others. It enables t …
  • NeuroMetrix Inc (NURO):企業の財務・戦略的SWOT分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a healthcare company company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, quell health cloud, DPNCheck point-of- …
  • Alaska Air Group, Inc.:企業の戦略・SWOT・財務情報
    Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alaska Air Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Setpoint Medical Inc-医療機器分野:企業M&A・提携分析
    Summary SetPoint Medical Inc. (SetPoint Medical) is a biotechnology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company employs a scientific platform, which is based on inflammatory reflex. The company’s bioelectronic medicine platform und …
  • SKY Network Television Limited (SKT):企業の財務・戦略的SWOT分析
    SKY Network Television Limited (SKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bank of Queensland Limited (BOQ):企業の財務・戦略的SWOT分析
    Bank of Queensland Limited (BOQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Middlesex Water Company (MSEX):企業の財務・戦略的SWOT分析
    Summary Middlesex Water Company (Middlesex Water) is a provider of water and wastewater management services. The company's services include water production, treatment and distribution, regulated and non-regulated water and wastewater utility services, working to promote economic development, and bu …
  • Naked Wines plc (WINE):企業の財務・戦略的SWOT分析
    Naked Wines plc (WINE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CritiTech Inc (CritiTech) is a pharmaceutical contract development manufacturing organization that specializes in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company uses Spray Drying and Supe …
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Solvay SA (SOLB)-エネルギー分野:企業M&A・提携分析
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates, vinyls and acetate tow. Its products include chemical products such as barium stron …
  • J. C. Penney Company, Inc.:企業の戦略・SWOT・財務情報
    J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sandoz International GmbH:企業の戦略・SWOT・財務分析
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grinners Catering (Australia) Pty Ltd
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆